CURE was established in 1975 thanks to Emory University pediatric oncologist, Dr. Abdel Ragab.
Dr. Ragab needed support to build a pediatric oncology research program. He organized a group of parents of his patients to form CURE and start raising money. At the time, the survival rate of children with cancer was a bleak ten percent. With a very real sense of urgency, CURE focused on improving the care and quality of life – as well as the survival rates – of children with cancer.
Since that time, we’ve helped increase the childhood cancer survival rate to 80%.
While that may sound impressive, it’s not good enough. Nothing less than 100% will ever be good enough. That’s why, over the years, we’ve expanded our mission to focus more heavily on research. It’s through research that we’ll find the cure for childhood cancer.
CURE funds research into the development of “targeted therapies.”
These treatments focus only on the cancer cells, keeping surrounding healthy cells safe and unharmed. The goal of targeted therapy is to spare patients the devastating and often life-threatening “late effects” caused by current conventional therapies. CURE continues to fund the testing of new therapies and drugs at Emory, the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta and other prominent institutions nationwide.
CURE also endows the training of future pediatric oncologists and researchers through the fellowship program at Emory University School of Medicine, supplies emergency financial assistance for families stricken by childhood cancer, and provides innovative programs that address the critical and urgent needs of patients and their families. These programs include meals to inpatient families, outreach at the time of diagnosis, and bereavement support.